Stockreport

Carl Zeiss: Significant Underperformance, Valuation At Multi-Year Lows [Seeking Alpha]

CARL ZEISS MEDI UNSP/ADR  (CZMWY) 
NASDAQ:AMEX Investor Relations: zeiss.com/meditec-ag/investor-relations.html
PDF Follow Summary Carl Zeiss Meditec has seen a 30%+ decline due to earnings and margin drops, but remains a strong market leader with significant long-term upside. [Read more]